Life Edit Therapeutics
Main (gene editing) focus: Novel gene- and cell therapies
Company stage: Pre-clinical
Diseases: Undisclosed
Genome editing tool: CRISPR-Cas, base editing, CRISPRa/CRISPRi
Funding stage: Private
Location: Research Triangle Park, North Carolina, USA
Website: https://www.lifeeditinc.com/
Partners: ElevateBio
Life Edit Therapeutics was recently acquired and is now a subsidiary of ElevateBio. The company develops multiple novel gene-editing technologies, including CRISPR-Cas, base editing and CRISPRa/CRISPRi systems. The company yet has to disclose its lead programmes.